Drug: |
PLX3397 + Pembrolizumab |
|||
---|---|---|---|---|
Trial: |
A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors |
|||
Conditions: | Solid Tumors | |||
Trial Status: |
Ongoing, but not recruiting |
Memorial Sloan Kettering1275 York Ave |
Principal Investigator: |
Dmitriy Zamarin, MD PhD |
---|---|
Contact: |
|
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Memorial Sloan Kettering Website: |
http://www.mskcc.org/mskcc/html/2270.cfm?Tab=All |
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.